Open AccessAcyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial
Author(s) -
Sanjay Singh,
Anurag Anurag,
Narendra Kumar Tiwary
Publication year - 2016
Publication title -
indian journal of dermatology, venereology, and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/0378-6323.182791
Subject(s) - pityriasis rosea , placebo , medicine , confidence interval , randomized controlled trial , erythema , dermatology , pathology , alternative medicine
Acyclovir is considered to be an effective treatment for pityriasis rosea but randomized, blinded, placebo-controlled trials have not been performed.